Kyrmanidou E, Kemanetzi C, Stavros C, et al. A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp. Dermatol Pract Concept. 2024;14(2):e2024119. doi:10.5826/dpc.1402a119